Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-006407
Filing Date
2024-02-22
Accepted
2024-02-22 17:01:35
Documents
1
Period of Report
2024-02-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1708639272.html 4  
1 FORM 4 wk-form4_1708639272.xml 4 3992
  Complete submission text file 0001628280-24-006407.txt   5475
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Issuer) CIK: 0001619856 (see all company filings)

EIN.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O GLOBAL BLOOD THERAPEUTICS 171 OYSTER POINT BLVD, STE. 300 SAN FRANCISCO CA 94080
Business Address
JOHNSON DAVID LEE (Reporting) CIK: 0001733883 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40631 | Film No.: 24665878